Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Diverging prognostic impacts of hypoxic markers according to NSCLC histology.

Andersen S, Eilertsen M, Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM.

Lung Cancer. 2011 Jun;72(3):294-302. doi: 10.1016/j.lungcan.2010.10.006. Epub 2010 Nov 13.

PMID:
21075472
2.

Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.

Malentacchi F, Simi L, Nannelli C, Andreani M, Janni A, Pastorekova S, Orlando C.

Lung Cancer. 2009 Jun;64(3):271-6. doi: 10.1016/j.lungcan.2008.10.001. Epub 2008 Nov 20.

PMID:
19022520
3.

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC, Harris AL.

J Pathol. 2003 Jun;200(2):222-8.

PMID:
12754744
4.

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.

Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, Havet K, Venissac N, Mograbi B, Mouroux J, Pouysségur J, Hofman P.

Br J Cancer. 2010 May 25;102(11):1627-35. doi: 10.1038/sj.bjc.6605690. Epub 2010 May 11.

6.

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL; Tumour and Angiogenesis Research Group.

Br J Cancer. 2003 Sep 1;89(5):877-85.

7.

Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.

Cleven AH, van Engeland M, Wouters BG, de Bruïne AP.

Cell Oncol. 2007;29(3):229-40.

8.

Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1481-7. Epub 2006 Oct 23.

PMID:
17056190
9.

Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma.

Roh JL, Cho KJ, Kwon GY, Choi SH, Nam SY, Kim SY.

J Surg Oncol. 2008 Jun 1;97(7):596-600. doi: 10.1002/jso.21045.

PMID:
18449879
10.

Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.

Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ.

Thorax. 2009 Dec;64(12):1082-9. doi: 10.1136/thx.2009.115691. Epub 2009 Sep 23. Review.

PMID:
19778933
11.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL.

Clin Cancer Res. 2002 Aug;8(8):2595-604.

12.

Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

Seeber LM, Horrée N, van der Groep P, van der Wall E, Verheijen RH, van Diest PJ.

BMC Cancer. 2010 Jun 19;10:307. doi: 10.1186/1471-2407-10-307.

13.

Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL.

Cancer Res. 2001 Nov 1;61(21):7992-8.

14.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
15.

Fibrotic focus and hypoxia in male breast cancer.

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ.

Mod Pathol. 2012 Oct;25(10):1397-404. doi: 10.1038/modpathol.2012.101. Epub 2012 Jun 8.

16.

Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia.

Mayer A, Höckel M, Wree A, Leo C, Horn LC, Vaupel P.

Cancer Res. 2008 Jun 15;68(12):4719-26. doi: 10.1158/0008-5472.CAN-07-6339.

17.

Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis.

Koukourakis MI, Pitiakoudis M, Giatromanolaki A, Tsarouha A, Polychronidis A, Sivridis E, Simopoulos C.

Cancer Sci. 2006 Oct;97(10):1056-60.

18.

The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.

Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, Corbridge RJ, Cox GJ, Harris AL.

Cancer. 2006 Aug 15;107(4):757-66.

19.

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska-Narloch A, Gulida G, Rzepko R, Biernat W, Taron M, Jelitto-Górska M, Marjański T, Rzyman W, Rosell R, Jassem J.

Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.

PMID:
23870818
20.

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.

Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH.

BMC Cancer. 2011 May 12;11:167. doi: 10.1186/1471-2407-11-167.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk